Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Starr

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Oncologist|March 13, 2024
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine CarcinomaBlake J McKinley, Tucker W Coston, Jason S Starr
Expert Review of Endocrinology & Metabolism|July 19, 2023
Understanding the increasing incidence of neuroendocrine tumorsSurabhi Pathak, Jason S Starr, Thorvardur Halfdanarson, et al.
Cureus|August 7, 2023
A Unicorn Disease: The Large Duct Variant of Invasive Ductal Adenocarcinoma of the PancreasAhmed Elhariri, Jason S Starr, Sanjay Bagaria, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|July 6, 2023
Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine NeoplasmsOsama Mosalem, Mohamad Bassam Sonbol, Thorvardur R Halfdanarson, et al.
Cardio-Oncology (London, England)|March 11, 2020
5-FU induced cardiotoxicity: case series and review of the literatureCai Yuan, Hiral Parekh, Carmen Allegra, et al.
Clinical Advances in Hematology & Oncology : H&O|September 8, 2021
Management of well-differentiated neuroendocrine tumorsSri Harsha Tella, Jason S Starr, Anuhya Kommalapati, et al.
Journal of Pancreatic Cancer|July 25, 2019
Two Cases of Rare Pancreatic MalignanciesWissam Hanayneh, Hiral Parekh, Garrett Fitzpatrick, et al.
Journal of Oncology Practice|July 12, 2017
Management of Malignant Bowel Obstruction Associated With GI CancersAaron J Franke, Atif Iqbal, Jason S Starr, et al.
Expert Opinion on Investigational Drugs|April 24, 2023
Targeting leukemia inhibitory factor in pancreatic adenocarcinomaJing Wang, Christian Karime, Umair Majeed, et al.
Clinical Advances in Hematology & Oncology : H&O|January 13, 2023
Treatment landscape of advanced high-grade neuroendocrine neoplasmsSamee Zane Alheraki, Daniel R Almquist, Jason S Starr, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Oncologist|March 13, 2024
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine CarcinomaBlake J McKinley, Tucker W Coston, Jason S Starr
Expert Review of Endocrinology & Metabolism|July 19, 2023
Understanding the increasing incidence of neuroendocrine tumorsSurabhi Pathak, Jason S Starr, Thorvardur Halfdanarson, et al.
Cureus|August 7, 2023
A Unicorn Disease: The Large Duct Variant of Invasive Ductal Adenocarcinoma of the PancreasAhmed Elhariri, Jason S Starr, Sanjay Bagaria, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|July 6, 2023
Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine NeoplasmsOsama Mosalem, Mohamad Bassam Sonbol, Thorvardur R Halfdanarson, et al.
Cardio-Oncology (London, England)|March 11, 2020
5-FU induced cardiotoxicity: case series and review of the literatureCai Yuan, Hiral Parekh, Carmen Allegra, et al.
Clinical Advances in Hematology & Oncology : H&O|September 8, 2021
Management of well-differentiated neuroendocrine tumorsSri Harsha Tella, Jason S Starr, Anuhya Kommalapati, et al.
Journal of Pancreatic Cancer|July 25, 2019
Two Cases of Rare Pancreatic MalignanciesWissam Hanayneh, Hiral Parekh, Garrett Fitzpatrick, et al.
Journal of Oncology Practice|July 12, 2017
Management of Malignant Bowel Obstruction Associated With GI CancersAaron J Franke, Atif Iqbal, Jason S Starr, et al.
Expert Opinion on Investigational Drugs|April 24, 2023
Targeting leukemia inhibitory factor in pancreatic adenocarcinomaJing Wang, Christian Karime, Umair Majeed, et al.
Clinical Advances in Hematology & Oncology : H&O|January 13, 2023
Treatment landscape of advanced high-grade neuroendocrine neoplasmsSamee Zane Alheraki, Daniel R Almquist, Jason S Starr, et al.
Pageof 4